AbbVie, Genmab post trial setback for lymphoma drug (ABBV:NYSE)

AbbVie, Genmab post trial setback for lymphoma drug (ABBV:NYSE)  Seeking Alpha

Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.